These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 3011902)

  • 41. Fc gamma R-mediated killing by eosinophils.
    Graziano RF; Looney RJ; Shen L; Fanger MW
    J Immunol; 1989 Jan; 142(1):230-5. PubMed ID: 2521234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cells in peripheral blood and the mixed lymphocyte response: interaction with the transferrin receptor.
    Salmon M; Bacon PA; Young SP
    Immunology; 1987 Sep; 62(1):81-7. PubMed ID: 2958408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human monocytes and U937 cells bear two distinct Fc receptors for IgG.
    Looney RJ; Abraham GN; Anderson CL
    J Immunol; 1986 Mar; 136(5):1641-7. PubMed ID: 2936805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC; Hargrove ME; Yun YS
    J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural requirements of immunoglobulin G for binding to the Fc gamma receptors of the human tumor cell lines U937, HL-60, ML-1, and K562.
    McCool D; Birshtein BK; Painter RH
    J Immunol; 1985 Sep; 135(3):1975-80. PubMed ID: 3860563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and structural analysis of Fc gamma receptors of human monocytes, a monoblast cell line (U937) and a myeloblast cell line (HL-60) by a monoclonal antibody.
    Frey J; Engelhardt W
    Eur J Immunol; 1987 May; 17(5):583-91. PubMed ID: 2953612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.
    Ullberg M; Jondal M
    Clin Exp Immunol; 1983 Jul; 53(1):101-8. PubMed ID: 6872324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoclonal antibodies against SSEA-1 antigen: binding properties and inhibition of human natural killer cell activity against target cells bearing SSEA-1 antigen.
    Harris JF; Chin J; Jewett MA; Kennedy M; Gorczynski RM
    J Immunol; 1984 May; 132(5):2502-9. PubMed ID: 6143780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.
    Rola-Pleszczynski M; Lieu H; Sullivan AK; Girard M
    J Clin Invest; 1985 Nov; 76(5):1927-31. PubMed ID: 2932473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells.
    Adachi M; Yodoi J; Noro N; Masuda T; Uchino H
    J Immunol; 1984 Jul; 133(1):65-71. PubMed ID: 6233376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii.
    Erbe DV; Pfefferkorn ER; Fanger MW
    J Immunol; 1991 May; 146(9):3145-51. PubMed ID: 1826707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
    Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
    J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.
    Ramos OF; Patarroyo M; Yefenof E; Klein E
    J Immunol; 1989 Jun; 142(11):4100-4. PubMed ID: 2565929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Definition of a "trigger" stage in the NK cytolytic reaction sequence by a monoclonal antibody to the glycoprotein T-200.
    Targan SR; Newman W
    J Immunol; 1983 Sep; 131(3):1149-53. PubMed ID: 6886418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a putative antigen receptor on fish nonspecific cytotoxic cells with monoclonal antibodies.
    Evans DL; Jaso-Friedmann L; Smith EE; St John A; Koren HS; Harris DT
    J Immunol; 1988 Jul; 141(1):324-32. PubMed ID: 2454262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.